首页 > 市场调查报告书 > 医疗设备

生技设备

生物银行市场规模、份额和成长分析（按产品和服务、生物样本库类型、样本类型、储存方法、所有权、应用、最终用户和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1898697

生物银行市场规模、份额和成长分析（按产品和服务、生物样本库类型、样本类型、储存方法、所有权、应用、最终用户和地区划分）—产业预测（2026-2033 年）

Biobanking Market Size, Share, and Growth Analysis, By Product &Service (Equipment, Consumables), By Biobanks Type, By Sample Type, By Storage Type, By Ownership, By Application, By End user, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，生物银行市场规模将达到 769 亿美元，到 2025 年将达到 821.2 亿美元，到 2033 年将达到 1390.1 亿美元，在预测期（2026-2033 年）内，复合年增长率为 6.8%。

在技术创新、数据分析和自动化的推动下，生物银行产业正经历显着的扩张。这项发展催生了虚拟生物样本库的出现，不仅提高了传统生物样本库的运作效率，也释放了巨大的市场潜力。包括疾病相关生物样本库、人源生物样本库、组织样本库和血库在内的各类生物样本库，构成了一个多元化的市场格局，并受益于退化性疾病的日益增加。最尖端科技的整合加速了研究方法的改进，最大限度地缩短了处理时间，提高了生物样本库的收入，最终提升了整体市场价值。此外，旨在优化生物银行营运和促进虚拟系统应用的软体开发投入不断增加，也推动了生物银行市场的强劲成长。

生物银行市场驱动因素

生物银行市场的主要驱动力是基因组研究的拓展和个人化医疗的进步。人们对遗传标记与疾病进展之间关联的理解不断加深，促使生物样本库需要储存高品质的生物样本用于基因组分析。这些生物样本在帮助研究人员开发标靶治疗发挥关键作用，使生物样本库处于新兴医疗创新领域的前沿。对生物银行日益增长的依赖性表明，它在促进个人化治疗方法的突破和改善整体医疗保健效果方面至关重要。

生物银行市场的限制

生物银行市场面临许多限制因素，其中涉及生物样本的采集、储存和使用方面的伦理和法律问题。对病患隐私、知情同意以及敏感资料潜在滥用的担忧，为生物样本库的建立和运作带来了巨大挑战。这些问题削弱了公众的信任和接受度，使得生物样本库难以在现有的监管框架下有效运作。如何在严格遵守伦理标准与确保透明度和保密性之间取得平衡，仍然是一个重大障碍，影响着生物银行业务的整体成长和永续性。

生物银行市场趋势

生物银行市场正经历一个显着的趋势：人工智慧 (AI) 与巨量资料分析的融合。这种技术融合能够实现更精准的检体追踪、优化资料管理并提升检体保存品质。 AI 驱动的分析使研究人员能够从海量生物样本资料集中发现模式并获得洞见，从而帮助识别新的生物标记并加速药物研发倡议。透过利用这些先进技术，生物样本库不仅提高了营运效率，还为个人化医疗和创新疗法的突破性进展做出了贡献，使其成为生物医学研究领域的核心参与者。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Thermo Fisher Scientific Inc.（United States）
Merck KGaA（Germany）
QIAGEN NV（Netherlands）
Hamilton Company（United States）
Tecan Trading AG（Switzerland）
Becton, Dickinson and Company（BD）（United States）
Lonza Group AG（Switzerland）
Charles River Laboratories International, Inc.（United States）
BioLife Solutions, Inc.（United States）
Brooks Automation, Inc.（United States）
Greiner Bio-One International GmbH（Austria）
STEMCELL Technologies Inc.（Canada）
Chart Industries, Inc.（United States）
BioIVT（United States）
Firalis SA（France）
Celltex Therapeutics Corporation（United States）
Sigma-Aldrich Corporation（United States）
Hope Biosciences（United States）
54Gene（Nigeria）

结论与建议

简介目录

Product Code: SQMIG35H2200

Biobanking Market size was valued at USD 76.9 Billion in 2024 and is poised to grow from USD 82.12 Billion in 2025 to USD 139.01 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The biobanking sector is experiencing significant expansion, fueled by technological advancements, data analytics, and automation. This evolution has led to the emergence of virtual biobanks, which enhance the operational efficiency of traditional biobanks, unlocking substantial market potential. Various types of biobanks, including disease-related, human-based, tissue, and blood banks, contribute to a diverse landscape, particularly benefiting from the increasing prevalence of degenerative diseases. The integration of cutting-edge technologies accelerates the research process, minimizes processing times, and enhances revenue generation for biobanks, subsequently elevating the overall market value. Furthermore, software development initiatives are on the rise, aimed at optimizing biobanking operations and promoting the adoption of virtual systems, which collectively drive robust growth within the biobanking market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biobanking market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biobanking Market Segments Analysis

Global Biobanking Market is segmented by Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user and region. Based on Product &Service, the market is segmented into Equipment, Consumables, Services and Software. Based on Biobanks Type, the market is segmented into Physical/Real Biobanks, Tissue Biobanks, Population Based Biobanks, Genetic (DNA/RNA), Disease Based Biobanks and Virtual Biobanks. Based on Sample Type, the market is segmented into Blood Products, Human Tissues, Cell Lines, Nucleic Acids, Biological Fluids and Human Waste Products. Based on Storage Type, the market is segmented into Manual Storage and Automated Storage. Based on Ownership, the market is segmented into Universities, National/Regional Agencies, Non-Profit Organizations and Private Organizations. Based on Application, the market is segmented into Regenerative Medicine, Life Science Research and Clinical Research. Based on End user, the market is segmented into Pharmaceutical, Biotechnology Companies and CROs, Academic, Research Institutes and Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biobanking Market

A significant catalyst for the biobanking market is the expanding landscape of genomics research and the advancement of personalized medicine. With increased comprehension of genetic markers and their relation to disease progression, there is a heightened need for biobanks that preserve high-quality biosamples for genomic analysis. These biosamples play a critical role in enabling researchers to develop targeted therapies, thereby positioning biobanks at the forefront of emerging healthcare innovations. This growing reliance on biobanking underscores its vital importance in facilitating breakthroughs in personalized treatment approaches and enhancing overall healthcare outcomes.

Restraints in the Biobanking Market

In the biobanking market, significant constraints arise from the ethical and legal considerations associated with the collection, storage, and utilization of biospecimens. Concerns regarding patient privacy, informed consent, and potential misuse of sensitive data pose considerable challenges to the establishment and operation of biobanks. These issues can hinder public trust and acceptance, making it difficult for biobanks to function effectively within the existing regulatory landscape. The need to balance stringent compliance with ethical standards while ensuring transparency and confidentiality remains a critical obstacle, impacting the overall growth and sustainability of biobanking initiatives.

Market Trends of the Biobanking Market

The biobanking market is witnessing a significant trend characterized by the integration of artificial intelligence (AI) and big data analytics. This technological fusion enhances specimen tracking, optimizes data management, and elevates the quality of specimen storage. AI-driven analytics empower researchers to uncover patterns and derive insights from extensive biosample datasets, thereby facilitating the identification of new biomarkers and expediting drug development initiatives. As biobanks harness these advanced technologies, they not only improve operational efficiencies but also contribute to groundbreaking advancements in personalized medicine and innovative therapeutic solutions, positioning themselves as pivotal players in the biomedical research landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Biobanking Market Size by Product &Service & CAGR (2026-2033)

Market Overview
Equipment
- Storage Equipment
- Sample Analysis Equipment
- Sample Processing Equipment
- Sample Transport Equipment
Consumables
- Storage Consumables
- Analysis Consumables
- Processing Consumables
- Collection Consumables
Services
- Storage Services
- Processing Services
- Transport Services
- Supply Services
Software

Global Biobanking Market Size by Biobanks Type & CAGR (2026-2033)

Market Overview
Physical/Real Biobanks
Tissue Biobanks
Population Based Biobanks
Genetic (DNA/RNA)
Disease Based Biobanks
Virtual Biobanks

Global Biobanking Market Size by Sample Type & CAGR (2026-2033)

Market Overview
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products

Global Biobanking Market Size by Storage Type & CAGR (2026-2033)

Market Overview
Manual Storage
Automated Storage

Global Biobanking Market Size by Ownership & CAGR (2026-2033)

Market Overview
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations

Global Biobanking Market Size by Application & CAGR (2026-2033)

Market Overview
Regenerative Medicine
Life Science Research
Clinical Research

Global Biobanking Market Size by End user & CAGR (2026-2033)

Market Overview
Pharmaceutical
Biotechnology Companies and CROs
Academic
Research Institutes
Hospitals

Global Biobanking Market Size & CAGR (2026-2033)

North America (Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user)
- US
- Canada
Europe (Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user)
- Brazil
- Rest of Latin America
Middle East & Africa (Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tecan Trading AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLife Solutions, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brooks Automation, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Greiner Bio-One International GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STEMCELL Technologies Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chart Industries, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioIVT (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Firalis S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celltex Therapeutics Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hope Biosciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
54Gene (Nigeria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

Conclusion & Recommendations

02-2729-4219

+886-2-2729-4219

License/价格

生物银行市场规模、份额和成长分析（按产品和服务、生物样本库类型、样本类型、储存方法、所有权、应用、最终用户和地区划分）—产业预测（2026-2033 年）

Biobanking Market Size, Share, and Growth Analysis, By Product &Service (Equipment, Consumables), By Biobanks Type, By Sample Type, By Storage Type, By Ownership, By Application, By End user, By Region - Industry Forecast 2026-2033

目录

介绍

调查方法

执行摘要

市场动态与展望

关键市场考察

全球生物银行市场规模（依产品及服务划分）及复合年增长率（2026-2033 年）

全球生物银行市场规模（依生物样本库类型及复合年增长率划分）（2026-2033 年）

全球生物银行市场规模（按样本类型和复合年增长率划分）（2026-2033 年）

全球生物银行市场规模（按储存类型划分）及复合年增长率（2026-2033 年）

全球生物银行市场规模（按所有权和复合年增长率划分）（2026-2033 年）

全球生物银行市场规模（按应用领域划分）及复合年增长率（2026-2033 年）

全球生物银行市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

全球生物银行市场规模及复合年增长率（2026-2033）